STAGNO, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 1.001
AS - Asia 467
EU - Europa 454
SA - Sud America 152
AF - Africa 115
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.190
Nazione #
US - Stati Uniti d'America 978
IT - Italia 210
SG - Singapore 207
CN - Cina 147
BR - Brasile 140
IE - Irlanda 90
CI - Costa d'Avorio 75
DE - Germania 39
IN - India 33
SN - Senegal 28
UA - Ucraina 22
KR - Corea 21
RU - Federazione Russa 19
VN - Vietnam 19
CA - Canada 18
GB - Regno Unito 14
FI - Finlandia 13
SE - Svezia 9
TR - Turchia 8
AR - Argentina 6
CZ - Repubblica Ceca 6
UZ - Uzbekistan 6
IQ - Iraq 5
KE - Kenya 5
NL - Olanda 5
ES - Italia 4
FR - Francia 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BD - Bangladesh 3
BE - Belgio 3
LB - Libano 3
MA - Marocco 3
MX - Messico 3
PY - Paraguay 3
EC - Ecuador 2
GR - Grecia 2
HK - Hong Kong 2
JO - Giordania 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
CH - Svizzera 1
DO - Repubblica Dominicana 1
EU - Europa 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 2.190
Città #
Santa Clara 199
Chandler 169
Singapore 136
Chicago 101
Dublin 90
Abidjan 75
Dallas 58
Catania 46
Ashburn 39
Hefei 39
Civitanova Marche 33
Boardman 32
Dakar 27
Beijing 25
Kochi 25
Cambridge 23
Lawrence 23
Andover 22
Houston 22
Seoul 21
Jacksonville 18
Los Angeles 18
Dong Ket 14
Munich 14
São Paulo 14
Des Moines 13
Grafing 13
The Dalles 13
Nanjing 12
Palermo 12
Wilmington 12
Columbus 9
Milan 8
New York 7
Ottawa 7
Turku 7
Belo Horizonte 6
Brooklyn 6
Hanover 6
Saint Petersburg 6
Toronto 6
Council Bluffs 5
Falls Church 5
Giardini-Naxos 5
Hanoi 5
Helsinki 5
Jiaxing 5
Rome 5
Bari 4
Boston 4
Brno 4
Hebei 4
Jinan 4
Montreal 4
Nairobi 4
Nanchang 4
Rio de Janeiro 4
Santa Venerina 4
Belém 3
Bremen 3
Brussels 3
Dubai 3
Florence 3
Istanbul 3
Juiz de Fora 3
Osasco 3
Seattle 3
Tremestieri Etneo 3
Washington 3
Zhengzhou 3
Abuja 2
Aci Catena 2
Amman 2
Assago 2
Asunción 2
Bauru 2
Bergamo 2
Buenos Aires 2
Campinas 2
Canoinhas 2
Casablanca 2
Comiso 2
Cotia 2
Curitiba 2
Frankfurt am Main 2
Fremont 2
Guarulhos 2
Johannesburg 2
Manchester 2
Messina 2
Newham 2
Pace del Mela 2
Porto Seguro 2
Pune 2
Redwood City 2
San Giovanni la Punta 2
San Mateo 2
Sant'Agata di Militello 2
Shenyang 2
Siracusa 2
Totale 1.597
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 161
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 109
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 104
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 102
In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside 99
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 96
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 93
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 92
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 89
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 89
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 86
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 85
Uncommon long-term survival in a patient with chronic myeloid leukemia 81
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 80
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 78
A case of high-risk AML in a patient with advanced systemic mastocytosis 77
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 77
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 76
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 74
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 74
Evaluation of taxol cytotoxicity on B-CLL cells in vitro 71
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 67
Differences among young adults, adults and elderly chronic myeloid leukemia patients 65
Low serum levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in IFN-treated chronic myeloid leukemia (CML) patients 64
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 63
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper 53
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions 41
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 20
Totale 2.266
Categoria #
all - tutte 8.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 5 11 29 7 8 1 17 1 5 16
2021/2022164 4 24 3 3 34 5 27 4 9 1 9 41
2022/2023432 28 48 16 50 31 64 1 80 85 5 18 6
2023/2024251 13 40 8 12 8 66 1 15 5 10 50 23
2024/2025902 12 147 37 83 171 115 77 36 34 52 90 48
2025/2026240 106 125 9 0 0 0 0 0 0 0 0 0
Totale 2.266